Hormonal Coc Spiro denied for failing step therapy by Cigna?

Cigna's specific coverage criteria for hormonal coc spiro are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Apply Step-Therapy Requirements to Combined COC + Spironolactone

Step-therapy (also called "fail-first") denials require that a patient try one or more less expensive or preferred alternatives before the plan will cover the requested therapy. For a combined COC and spironolactone regimen, Cigna may require documented trials of individual monotherapy agents, alternative contraceptive formulations, or other first-line treatments for the underlying condition before approving the combination.

Step-therapy denials are frequently overturned when the prescriber documents that required step medications were already tried and failed, caused adverse effects, or are clinically contraindicated for the specific patient. Many states have enacted step-therapy override laws that apply to fully-insured plans, and employer-sponsored plans are subject to ERISA standards requiring that step protocols be clinically sound.

## Your Federal Appeal Rights

ACA Section 2719 requires internal appeal followed by independent external review. ERISA Section 503 applies to employer-sponsored plans. External review must generally be requested within approximately four months of the final internal denial. Request expedited review if your clinical situation is urgent.

If your plan is a fully-insured plan in a state with a step-therapy override law, your prescriber may be able to invoke a clinical exception on the grounds that the step medication is contraindicated, clinically inappropriate, or was previously tried and failed.

## Appeal Process and Timeline

1. Obtain the denial letter identifying which step medications Cigna requires. 2. Audit your treatment history with your prescriber — prior trials of step agents may already be in your chart. 3. Request a step-therapy exception (if available under your plan or state law) with prescriber documentation. 4. File a formal internal appeal if the exception is denied. 5. Request external review if the internal appeal is upheld.

## Documentation to Gather

• Prior treatment history: Dates, agents, and documented outcomes for every step medication required by Cigna — this is the central piece of evidence.
• Adverse effect documentation: Chart notes describing any adverse effects from step agents that preclude their use.
• Diagnosis and severity records: Documentation establishing the condition and its severity, particularly if severity warrants bypassing step requirements.
• Prescriber's medical-necessity letter: Should address each required step agent individually, explaining what happened when it was tried (or why it cannot be tried), and why the combination therapy is now medically necessary.

## Criteria-Mapping Structure

List each step requirement from Cigna's coverage policy and respond to each one:

| Required Step Agent | Chart Documentation | |---|---| | [Step 1 agent as listed in Cigna's policy] | Dates tried, outcome, reason for discontinuation | | [Step 2 agent if required] | Same format | | Clinical exception basis (if applicable) | Contraindication, clinical inappropriateness, or documented failure |

Verify with your prescriber that the documented step trials and the requested combination are consistent with the FDA-approved prescribing labels for each agent, and that the appeal letter references the applicable specialty guideline organization supporting the combination as appropriate after step failure.